fda approval semaglutide Approves Oral as First GLP-1 Pill for Weight Loss Medicine Guide – Tagged "FDA
Description
This can reduce the likelihood of overeating and snacking between meals, helping maintain the calorie deficit needed to meet weight loss goals

doi: 10.1542/peds.2020-044982
People who did not get the weight reduction they wanted with semaglutide or tirzepatide can get this too

However, the authors noted that few patients remained at risk after five years, limiting the precision of later 10-year RFS estimates
Contact your GP if you experience: Persistent metallic taste lasting beyond 23 weeks despite self-management strategies Complete loss of taste (ageusia) or significant taste distortion affecting nutritional intake Taste changes accompanied by other concerning symptoms such as severe nausea or vomiting Inability to keep fluids down or signs of dehydration (excessive thirst, dry mouth, dark urine, dizziness) Oral symptoms including mouth ulcers, swelling, pain, or signs of infection Difficulty maintaining adequate food or fluid intake due to taste disturbance Symptoms suggestive of hypoglycaemia, particularly if taking Ozempic with insulin or sulphonylureas (sweating, shakiness, confusion) [1] [2] Seek same-day medical advice if you have persistent vomiting with signs of dehydration or cannot keep fluids down

I have enjoyed the team at Genesis who created a realistic plan that has made me successful
